Richards Group Inc. reported revenue growth of 5.2% for the quarter ended June 30, 2026, with the company attributing the increase mainly to two acquisitions rather than to underlying demand across its business.
The acquired businesses named in the release are DermapenWorld, bought in June 2025, and PharmaSystems, bought in May 2026. The company also said gross margins — the share of revenue left after the direct cost of the goods sold — rose 18.4%, again crediting the acquisitions.
The Mississauga, Ontario company runs two segments. In healthcare, organic revenue, meaning revenue excluding acquired operations, was up 7.3%. Richards said the growth came from consumables and lower-priced capital equipment across its aesthetics and pharmacy lines.
Packaging moved the other way. Revenue in that segment fell 11.5%, which the company described as an improvement on the 17.2% decline recorded in the first quarter and as a continuing reflection of macroeconomic conditions. On the figures given, the healthcare gain and the acquisitions were enough to offset the packaging shortfall at the group level.
Richards also said it completed a normal course issuer bid — a share buyback conducted through the market under Canadian exchange rules — purchasing 450,926 shares. The release did not state what was paid for them, what proportion of outstanding shares they represent, or the total shares now issued.
Chief Executive Officer John Glynn said in the release that the company's "2030 Vision is bearing fruit," pointing to healthcare growth and margin improvement from customer and product mix, and describing the quarter as "crossing an inflection point in earnings and cash flow generation." No earnings or cash flow figures accompanied that statement.
That is the main limitation of the announcement. Every operating metric in it is a percentage change. The release does not disclose absolute revenue, gross profit, net income or loss, cash on hand, debt, or the purchase price of PharmaSystems, the acquisition that closed during the quarter. Because the reported top-line growth is credited to acquisitions, the release as written does not allow a reader to separate what was bought from what was earned, or to see what the buying cost. Richards said full results were available on its website and on SEDAR+, Canada's regulatory filing system.
Richards Group trades on the Toronto Stock Exchange under the symbol RIC. The company says it was founded in 1912 and describes itself as the largest Canadian distributor of aesthetic, pharmacy and vision care devices and the third largest in Canadian packaging.
Source: Newsfile
This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.